Cedars-Sinai Accelerator, today announced 11 new digital health startups selected to participate in its fifth class from across the United States and Europe. From artificial intelligence to a smart brace for knee replacement patients, these innovative healthcare-focused startups are working to transform health and healthcare delivery as part of the Los Angeles-based accelerator program. Through their innovations, the companies seek to address some of healthcare’s most pressing challenges,
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Syqe Medical Releases Pharmaceutical-Grade Medical Marijuana Inhaler
Syqe Medical, an Israeli pharma-tech company, recently launched its newest administering device for cannabis in the form of a non-combustion inhaler.
The Syqe Inhaler™ is the company’s flagship product that utilizes innovative technology to administer proper doses of cannabis for medical marijuana patients in Israel. Syqe’s breakthrough drug delivery technology introduces complex respiration technique automation, electronic selective dosing, remote clinical monitoring and dose
Read More
Washington University Alzheimer’s Study Adopts BYOD Technology for Clinical Trials & Observational Study
The Washington University School of Medicine in Saint Louis has selected Datacubed Health’s mobile platform has been selected to support worldwide studies for those at risk of Dominantly Inherited Alzheimer’s Disease, a rare form of early-onset Alzheimer’s Disease. The Linkt platform enables the collection of real-time data on sleep, diet and other biomarkers using a “bring your own device” (BYOD) study model.Datacubed Health’s app, platform and web-based portal will be used by scientists at the
Read More
Medable Launches Telemedicine Solution to Improve Data-Driven Virtual Clinical Trials
Medable Inc., a Silicon Valley-based provider of data driven and digitally enabled clinical trials has announced the launch of their global Trial-Fit™ Telemedicine Solution designed to address critical trial barriers of low patient retention and lack of access. Medable’s Trial-Fit Telemedicine enables sites all over the world to conduct secure, HIPAA-compliant video consultations with clinical study participants in an integrated eCOA solution. Medable telemedicine is the only integrated,
Read More
SubjectWell Raises $10M to Expand Risk-Free Clinical Trials Marketplace for Patient Recruitment
SubjectWell, an Austin, TX-based risk-free clinical trials marketplace for patient recruitment has raised $10 million in Series A funding led by Windham Venture Partners, with participation from previous investors Healthy Ventures and Geekdom Fund.
SubjectWell
Clinical Trials Marketplace
Founded in 2012, SubjectWell is increasing participation in clinical research by providing a single marketplace that allows prospective patients to match to any available clinical trials. Instead of using
Read More
NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App
NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
BHE Raises $78M To Expand Real-World Evidence Analytics Platform
BHE, a Boston, MA-based innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners (“Silversmith”) and Leerink Transformation Partners (“LTP”). Instant Health DataThe use of real-world evidence (RWE) has grown rapidly within life sciences companies over the last several years, supported by the proliferation of large datasets, new computing technologies, and interest by both payers and regulatory agencies in understanding
Read More
Amgen, Syapse Partner to Develop Observational Research Analytics for Precision Oncology
Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the collaboration, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.Generates Insights from Real-World Evidence for Potential Use in Regulatory FilingsThis effort will identify existing patients within
Read More
Digital Twin Technology: Should Healthcare Jump on the Bandwagon?
While healthcare is known for not jumping to conclusions very fast when investing in new technology, the industry starts to pick up the pace. Such “newcomers” as blockchain, IoT, VR, and AR get a well-deserved appraisal and become an integral part of next-gen custom healthcare software aimed at supporting personalized treatment and predictable patient outcomes across a wide range of conditions.
We anticipate that the digital twin technology has good chances to become the next addition to the
Read More
EMV Capital Acquires Predictive Adverse Events Platform Wanda
EMV Capital, a London-based early-stage venture investor announced the acquisition and investment in Wanda Inc., a San Francisco-based digital health startup commercializing advanced clinical decision support software powered by machine learning and real-time patient data analysis. EMV Capital’s investment will enable Wanda to accelerate its growth in the North American market, as well as to enter the UK and European markets.Wanda Inc. BackgroundWanda Founded in 2011 from the results of eight
Read More
